Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) View Full Press Release Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Rare Revolution Magazine focuses on newborn screening (NBS) in recent issue co-sponsored by Travere Therapeutics